Faron Pharmaceuticals Oy (FARON.HE)
Faron Pharmaceuticals Oy operates as a clinical stage drug discovery and development company.
0.48+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-78.1%
The outlook
Faron Pharmaceuticals Oy currently reads as neutral based on strong buy — 1.0 avg of 4 analysts, below its 50- & 200-day averages, 2% of the way from its 52-week low to high, avg target +194% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 4 analysts
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +194% vs current price
Analyst price target
~12-month · 4 analysts1.41average target+193.7% vs now
Now 0.48
Low 0.75High 2.50
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$97.6M
52-wk high
2.77
52-wk low
0.44
50-day avg
0.50
200-day avg
1.16
Trailing P/E
—